For research use only. Not for therapeutic Use.
Fezakinumab is an interleukin-22 (IL-22) monoclonal antibody. Fezakinumab can be used for the research of inflammatory disease, such as psoriasis and rheumatoid arthritis[1].
| Catalog Number | I043163 |
| CAS Number | 1007106-86-6 |
| Purity | ≥95% |
| Reference | [1]. Patrick M Brunner, et al. Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab. J Allergy Clin Immunol |
